ZA200907240B - Cell lines, compositions comprising them for the treatment of melanomas, procedures to prepare the compositions, and treatment methods - Google Patents

Cell lines, compositions comprising them for the treatment of melanomas, procedures to prepare the compositions, and treatment methods

Info

Publication number
ZA200907240B
ZA200907240B ZA200907240A ZA200907240A ZA200907240B ZA 200907240 B ZA200907240 B ZA 200907240B ZA 200907240 A ZA200907240 A ZA 200907240A ZA 200907240 A ZA200907240 A ZA 200907240A ZA 200907240 B ZA200907240 B ZA 200907240B
Authority
ZA
South Africa
Prior art keywords
compositions
treatment
melanomas
procedures
prepare
Prior art date
Application number
ZA200907240A
Other languages
English (en)
Inventor
Jose Mordoh
Maria Marcela Barrio
Euw Erika Maria Von
Original Assignee
Consejo Nac Invest Cient Tec
Fundacion Sales
Inis Biotech Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Consejo Nac Invest Cient Tec, Fundacion Sales, Inis Biotech Llc filed Critical Consejo Nac Invest Cient Tec
Publication of ZA200907240B publication Critical patent/ZA200907240B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/00119—Melanoma antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/19—Dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/20—Cellular immunotherapy characterised by the effect or the function of the cells
    • A61K40/24—Antigen-presenting cells [APC]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/42—Cancer antigens
    • A61K40/4271—Melanoma antigens
    • A61K40/4272—Melan-A/MART
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/42—Cancer antigens
    • A61K40/4271—Melanoma antigens
    • A61K40/4273—Glycoprotein 100 [Gp100]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N13/00—Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5152—Tumor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/80—Vaccine for a specifically defined cancer
    • A61K2039/876—Skin, melanoma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
    • A61K2239/31—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterized by the route of administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA200907240A 2007-04-11 2009-10-16 Cell lines, compositions comprising them for the treatment of melanomas, procedures to prepare the compositions, and treatment methods ZA200907240B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ARP070101520A AR060424A1 (es) 2007-04-11 2007-04-11 Lineas celulares , composiciones para el tratamiento de melanomas que las comprenden procedimientos para preparar las composiciones y metodos de tratamiento

Publications (1)

Publication Number Publication Date
ZA200907240B true ZA200907240B (en) 2010-07-28

Family

ID=39590605

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200907240A ZA200907240B (en) 2007-04-11 2009-10-16 Cell lines, compositions comprising them for the treatment of melanomas, procedures to prepare the compositions, and treatment methods

Country Status (17)

Country Link
US (1) US8501168B2 (ko)
EP (1) EP2146742B1 (ko)
JP (1) JP5762738B2 (ko)
KR (1) KR101502518B1 (ko)
CN (1) CN101861163B (ko)
AR (1) AR060424A1 (ko)
AU (1) AU2008238909B2 (ko)
BR (1) BRPI0809767B1 (ko)
CA (1) CA2683629C (ko)
CO (1) CO6260100A2 (ko)
DK (1) DK2146742T3 (ko)
ES (1) ES2390130T3 (ko)
MX (1) MX2009010927A (ko)
NZ (1) NZ580533A (ko)
RU (1) RU2484134C2 (ko)
WO (1) WO2008126039A2 (ko)
ZA (1) ZA200907240B (ko)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6077735B2 (ja) * 2011-06-08 2017-02-08 日本電子株式会社 電子顕微鏡観察用染色剤および電子顕微鏡観察用試料の染色方法
SG11201401632WA (en) 2011-10-20 2014-05-29 California Stem Cell Inc Antigen presenting cancer vaccine
JP6077757B2 (ja) * 2012-04-17 2017-02-08 日本電子株式会社 電子顕微鏡観察用染色剤および電子顕微鏡観察用試料の染色方法
JP5921386B2 (ja) * 2012-08-27 2016-05-24 日本電子株式会社 電子顕微鏡観察用染色剤および電子顕微鏡観察用試料の染色方法
CN103146641B (zh) * 2013-02-06 2015-03-25 云南中科灵长类生物医学重点实验室 多能干细胞的传代方法及其用途
CN104990781B (zh) * 2015-06-29 2018-02-16 中国医学科学院皮肤病研究所 黑素细胞免疫组化苏木素—甲苯胺蓝双重复染法
TW202134430A (zh) 2019-12-03 2021-09-16 美商紐沃進公司 腫瘤細胞疫苗
RU2755233C1 (ru) * 2021-01-11 2021-09-14 Сергей Анатольевич Яргунин Способ лечения меланомы кожи IIb-IIc стадий
CN115074328B (zh) * 2022-06-21 2025-02-07 中国人民解放军空军军医大学 一种用于治疗黑素瘤的细胞株及其多效价全细胞疫苗与使用方法
WO2025224605A1 (en) 2024-04-23 2025-10-30 Consejo Nacional De Investigaciones Científicas Y Técnicas (Conicet) Sequential administration of anti-melanoma vaccine and anti-pd-1 monoclonal antibodies

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5882654A (en) * 1989-11-03 1999-03-16 Morton; Donald L. Polyvalent melanoma vaccine
EP0961824A4 (en) * 1996-07-10 2003-01-29 Immunex Corp METHOD FOR ACTIVATING DENTRITIC CELLS
ATE283069T1 (de) * 1996-08-16 2004-12-15 Univ Johns Hopkins Med Melanomzellinien, welche immundominante melanomantigene teilen und verfahren zu deren anwendung
AU2872199A (en) * 1998-02-20 1999-09-06 Rockefeller University, The Apoptotic cell-mediated antigen presentation to dendritic cells
ES2340358T3 (es) * 1999-10-15 2010-06-02 Baylor Research Institute Uso de lineas celulares alogenicas para cargar celulas que presentan antigenos para elicitar respuestas inmunes.
WO2001028583A2 (en) * 1999-10-18 2001-04-26 St. Vincent's Hospital And Medical Center Of New York Melanoma vaccine and methods of making and using same
US7015205B1 (en) * 1999-10-18 2006-03-21 St. Vincent's Hospital And Medical Center Of New York Melanoma vaccine and methods of making and using same
AU2403901A (en) * 1999-12-28 2001-07-09 Ichiro Azuma Maturation-promoting agent for immature dendritic cells
ES2292619T3 (es) * 2000-09-15 2008-03-16 Ortho-Mcneil Pharmaceutical, Inc. Composiciones y metodos para inducir respuestas citologicas especificas de la celula t.
US20030072737A1 (en) * 2000-12-29 2003-04-17 Michael Brines Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs
IL140796A0 (en) * 2001-01-08 2002-02-10 Hadasit Med Res Service An autologous anti-cancer vaccine
EP2149381A3 (en) * 2001-03-09 2010-05-05 Baylor Research Institute Method of treating malignancies through induction of blood immune responses
WO2003020884A2 (en) * 2001-08-14 2003-03-13 The Government Of The United States Of America As Represented By The Secretary Of Health And Human Services Method for rapid generation of mature dendritic cells
AU2002365187A1 (en) * 2001-11-07 2003-07-24 Mannkind Corporation Epitope synchronization in antigen presenting cells
CN102600461B (zh) * 2002-12-06 2017-07-14 西北生物治疗药物公司 给予体外部分成熟的树突细胞治疗肿瘤
CN101052726A (zh) * 2003-05-09 2007-10-10 森托科尔公司 IL－23p40特异性免疫球蛋白衍生蛋白、组合物、方法和用途
EP2591786B1 (en) * 2003-10-16 2017-04-12 Cancure Limited Immunomodulating compositions and uses therefor
RU2262941C2 (ru) * 2004-01-05 2005-10-27 Государственное учреждение Научно-исследовательский институт клинической иммунологии СО РАМН Способ иммунотерапии злокачественных опухолей головного мозга
US7850962B2 (en) * 2004-04-20 2010-12-14 Genmab A/S Human monoclonal antibodies against CD20
CA2565874C (en) * 2004-05-10 2017-10-03 Macrogenics, Inc. Humanized fc.gamma.riib-specific antibodies and methods of use thereof
RU2283129C1 (ru) * 2004-12-24 2006-09-10 Сергей Викторович Луценко Белковопептидный противоопухолевый композит, клеточный препарат, активированный этим композитом, и способ профилактики или лечения опухолей

Also Published As

Publication number Publication date
AU2008238909A1 (en) 2008-10-23
JP2010523141A (ja) 2010-07-15
ES2390130T3 (es) 2012-11-06
JP5762738B2 (ja) 2015-08-12
US20100183683A1 (en) 2010-07-22
AR060424A1 (es) 2008-06-18
EP2146742A2 (en) 2010-01-27
NZ580533A (en) 2012-08-31
CA2683629A1 (en) 2008-10-23
BRPI0809767B1 (pt) 2022-04-12
KR20090129501A (ko) 2009-12-16
CN101861163B (zh) 2013-06-12
RU2484134C2 (ru) 2013-06-10
MX2009010927A (es) 2010-02-11
AU2008238909B2 (en) 2013-11-07
CA2683629C (en) 2016-06-21
DK2146742T3 (da) 2012-10-22
CN101861163A (zh) 2010-10-13
WO2008126039A2 (en) 2008-10-23
KR101502518B1 (ko) 2015-03-13
BRPI0809767A2 (pt) 2014-09-23
US8501168B2 (en) 2013-08-06
WO2008126039A3 (en) 2008-12-11
CO6260100A2 (es) 2011-03-22
RU2009141593A (ru) 2011-05-20
EP2146742B1 (en) 2012-07-11

Similar Documents

Publication Publication Date Title
IL202015A0 (en) Methods and compositions for treating skin conditions
ZA200907240B (en) Cell lines, compositions comprising them for the treatment of melanomas, procedures to prepare the compositions, and treatment methods
SG10201608068SA (en) Compositions And Methods For Skin Care
IL220129A (en) History of benzamide, preparations containing them and their use in the treatment of cancer
IL202329A0 (en) Methods and compositions for stimulating cells
EP2429584A4 (en) TREATMENT PROCEDURE AND COMPOSITIONS
IL210810A0 (en) Compositions for the treatment of pain and/or inflamtion
SI2200431T1 (sl) Sestave in metode za zdravljenje raka
IL209032A0 (en) Compositions and methods for treating digestive disorders
PL2340042T3 (pl) Sposoby i kompozycje do leczenia raka
IL215592A0 (en) Compositions and methods for the treatment of inflammation
EP2244690A4 (en) METHOD AND COMPOSITIONS FOR THE TREATMENT OF SKIN DISEASES AND DRESSES
WO2012054862A9 (en) Agents, compositions, and methods for treating pruritis and related skin conditions
IL211018A (en) Inhibitors, processes for making them, medicinal preparations containing them and their use
GB0718446D0 (en) Compositions and methods for the treatment of infection
ZA201101278B (en) Compounds,compositions and methods for the treatment of b-amyloid diseases and synucleinopathies
EP2395980A4 (en) COMPOSITIONS AND METHODS FOR TREATING POST-OPERATIVE PAIN WITH BUPIVACAINE AND AN ANTI-INFLAMMATORY AGENT
PT2403336E (pt) Composições de tratamento de plantas e métodos para a sua utilização
PL2209458T3 (pl) Kompozycje do traktowania skóry
IL214349A0 (en) Compositions and methods for the treatment of cancer
GB0909297D0 (en) Composition for the treatment of skin conditions
GB0718918D0 (en) Compositions and methods for treating skin conditions
EP2152232A4 (en) METHOD AND COMPOSITIONS FOR OXYBUTYNINE ADMINISTRATION
PL2367420T3 (pl) Kompozycje do stosowania miejscowego zawierające cis-6-nonenol i jego pochodne oraz sposoby leczenia skóry
EP2381945A4 (en) TOPICAL FORMULAS OF FLAP INHIBITORS FOR THE TREATMENT OF DERMATOLOGICAL DISEASES